• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[源于不明原发部位的巨大转移性黑色素瘤]

[Giant metastatic melanoma arising from an unknown primary site].

作者信息

Ørndrup Mette Heisz, Crewe Bjørn, Stolle Lars Bjørn

机构信息

Plastikkirurgisk Afdeling, Z, -Aarhus Universitetshospital, Nørrebrogade 44, 8000 Aarhus C.

出版信息

Ugeskr Laeger. 2014 Jan 20;176(4A):V08130487.

PMID:25347250
Abstract

Metastatic melanoma arising from an unknown primary site (MUP) accounts for 1-8% of all melanomas. MUP is characterized by a better survival compared to a melanoma with known primary site. We report a case with a 55-year-old male with MUP and a 1.7 kg axillary lymph node metastasis, which was successfully excised. The patient was fully functional and alive 12 months after surgery. The reported favorable post-operative long-term survival of patients with MUP supports that these patients should be treated with an aggressive surgical approach with curative intent.

摘要

原发灶不明的转移性黑色素瘤(MUP)占所有黑色素瘤的1%-8%。与已知原发灶的黑色素瘤相比,MUP的特点是生存率更高。我们报告一例55岁男性MUP患者,其腋窝淋巴结转移灶重达1.7千克,该转移灶已成功切除。术后12个月,患者功能完全正常且存活。所报道的MUP患者术后长期良好生存率支持应对这些患者采取积极的、旨在治愈的手术方法进行治疗。

相似文献

1
[Giant metastatic melanoma arising from an unknown primary site].[源于不明原发部位的巨大转移性黑色素瘤]
Ugeskr Laeger. 2014 Jan 20;176(4A):V08130487.
2
Metastatic melanoma to lymph nodes in patients with unknown primary sites.原发部位不明患者的黑色素瘤淋巴结转移
Cancer. 2006 May 1;106(9):2012-20. doi: 10.1002/cncr.21835.
3
Bilateral oncocytic malignant melanoma in axillary lymph nodes without evidence of an extranodal primary.双侧腋窝淋巴结嗜酸性细胞性恶性黑色素瘤,无结外原发灶证据。
Ultrastruct Pathol. 2005 Sep-Oct;29(5):399-404. doi: 10.1080/019131290968731.
4
Melanoma without a detectable primary site with metastases to lymph nodes.无可检测到的原发部位且伴有淋巴结转移的黑色素瘤。
Dermatol Surg. 2010 Jun;36(6):868-76. doi: 10.1111/j.1524-4725.2010.01562.x. Epub 2010 May 7.
5
Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease.对于原发性肿瘤部位不明的黑色素瘤患者,在针对肉眼可见(临床可触及)的淋巴结疾病进行治疗性淋巴结清扫后,其预后比原发性肿瘤部位已知的患者更好。
Ann Surg Oncol. 2014 Sep;21(9):3108-16. doi: 10.1245/s10434-014-3679-5. Epub 2014 May 7.
6
Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma.不明原发黑色素瘤发生淋巴结转移后行淋巴结清扫术可提高生存率。
J Clin Oncol. 2008 Feb 1;26(4):535-41. doi: 10.1200/JCO.2007.14.0285.
7
Outcome after therapeutic lymph node dissection in patients with unknown primary melanoma site.原发灶不明的黑色素瘤患者行治疗性淋巴结清扫术后的结果。
Ann Surg Oncol. 2011 Dec;18(13):3586-92. doi: 10.1245/s10434-011-1801-5. Epub 2011 May 25.
8
Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.常规髂腹股沟淋巴结清扫术治疗可触及腹股沟黑色素瘤淋巴结转移的结果。
Br J Surg. 2014 Jun;101(7):811-9. doi: 10.1002/bjs.9502. Epub 2014 Apr 22.
9
Melanoma of unknown origin: a case series.不明来源黑色素瘤:病例系列。
Ir J Med Sci. 2010 Dec;179(4):629-32. doi: 10.1007/s11845-009-0405-6. Epub 2009 Jul 29.
10
Patients undergoing lymphadenectomy for stage III melanomas of known or unknown primary site do not differ in outcome.对于原发灶明确或未知的 III 期黑色素瘤行淋巴结清扫术的患者,其结局并无差异。
Int J Cancer. 2013 Dec 15;133(12):3000-7. doi: 10.1002/ijc.28318. Epub 2013 Aug 5.